The total number of prevalent cases of primary prevention dyslipidemia in the European countries under study will remain relatively stable over the 2016-2026 forecast period. The total number of…
The total number of prevalent cases of primary prevention dyslipidemia in the Asia-Pacific countries under study will increase by 13% over the forecast period, from 272 million in 2016 to 308…
DRG Epidemiology's coverage of T2D comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of T2D for each…
DRG Epidemiology’s coverage of prostate cancer comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of prostate…
Over the next ten years, more than 15 million men worldwide will be diagnosed with prostate cancer, resulting in nearly 3 million first-line drug-treatment opportunities in the metastatic castrate-…